FDA Warns of Bogus Claims by Makers of Hand Sanitizer
Some companies are selling hand sanitizers with unproven claims that they will protect against coronavirus disease 2019 (COVID-19).
Prevention
Prevention
Latest News
New Vial Size of HyperRAB Available for Rabies Postexposure Prophylaxis
HyperRAB for intramuscular injection is now available in 3 sizes: 1mL (300 IU), 3mL (900 IU) and 5mL (1500 IU) single-dose vials.
Infection Rate Up Prior to Detection of Malignant Cancer
The rate of infection with influenza, gastroenteritis, hepatitis, and pneumonia is increased before detection of malignant cancer.
FDA Approves Quadrivalent Meningococcal Vaccine MenQuadfi
The FDA has approved MenQuadfiTM Meningococcal (Groups A, C, Y, W; Sanofi Pasteur) Conjugate Vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y in patients aged ≥2 years.
Probiotics May Help Reduce Mild-to-Moderate Acne Symptoms
The use of probiotics as either an oral or topical treatment adjunct therapy may help in the management of acne vulgaris.
High Infection Prevalence Among Patients in the Intensive Care Unit
The global incidence of suspected or proven infection among patients admitted to the intensive care unit (ICU) was high in September 2017.
Darunavir/Ritonavir With Rifampicin May Be Hepatotoxic
Darunavir/ritonavir administered with rifampicin causes hepatotoxicities in people living with HIV.
USPSTF Against Bacterial Vaginosis Screening to Prevent Preterm Delivery
The U.S. Preventive Services Task Force recommends against screening for bacterial vaginosis in pregnant women not at increased preterm delivery risk.
Prophylaxis for Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
There remains considerable uncertainty on whether antibiotic prophylaxis for spontaneous bacterial peritonitis is beneficial in people with liver cirrhosis.
Countries’ Mitigation Measures Crucial for Containing Spread of COVID-19
The effect of COVID-19 response in China shows that quarantine, social distancing, and isolation of infected persons can contain the epidemic in other countries.
20-Valent Pneumococcal Conjugate Vaccine Safe, Immunogenic in Phase 3 Trial
Pfizer announced topline data from one of its phase 3 studies for 20vPnC for the prevention of invasive disease and pneumonia.
Medications for OUD Reduces Rates of Overdose and Endocarditis
Patients with opioid use disorder (OUD) who receive medications for OUD following endocarditis may experience improved health-related outcomes.
Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
Adherence to antimalarials may offer a protective effect against type 2 diabetes mellitus among patients with systemic lupus erythematosus.
Infection Prevention Is Widely Practiced Across Veterans Affairs Hospitals
Veterans Affairs hospitals adopted more infection prevention practices than non-VA hospitals.
Hand-Hygiene Adherence Varies at Critical Points of Care
Healthcare workers were more likely to partake in hand-hygiene protocols after contaminating tasks vs critical tasks and before such tasks.
CMV Exposure at Transplantation Is an Independent Predictor of Thrombotic Events
Donor cytomegalovirus seropositivity at transplantation was associated with an increased risk for thrombotic events post-transplantation.
CMV Vaccine May Prevent Viremia in Hematopoietic Stem Cell Transplant Recipients
Triplex, a modified recombinant attenuated poxvirus vaccine engineered to induce a virus-specific T-cell response to control CMV in recipients of allogeneic hematopoietic stem cell transplant was safe and well tolerated.
Harnessing Key Elements of the Ebola Virus in Animal Models of Glioblastoma
A glycoprotein in Ebola called the mucin-like domain may be of interest in the development of an oncolytic for brain cancer.
Vaccine to Prevent Ricin Intoxication Gets Fast Track Status
The FDA has granted Fast Track designation to RiVax® for the prevention of ricin intoxication.
Coagulation Disorders and Bleeding Risks With Cefoperazone-Sulbactam
Of patients who received cefoperazone-sulbactam, 9.2% reported a coagulation disorder and 15.7% reported a decrease in platelet count.
Want to read more?
Please login or register first to view this content.
Next post in Prevention
